Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

58.72
Delayed Data
As of Jul 22
 +0.48 / +0.82%
Today’s Change
26.80
Today|||52-Week Range
73.54
+30.13%
Year-to-Date
Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus
Jul 22 / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook
Jul 21 / Zacks.com - Paid Partner Content
AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4%
Jul 22 / Zacks.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5%
Jul 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close58.24
Today’s open58.31
Day’s range57.66 - 58.97
Volume100,216
Average volume (3 months)239,492
Market cap$674.9M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+33.36%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+36.36%
P/E ratio55.2
Price/Sales6.83
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...+0.08+0.88%
RTRXRetrophin Inc+0.35+1.97%
NTLAIntellia Therapeutic...-0.81-4.19%
ATRAAtara Biotherapeutic...+0.22+0.99%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Partner Offers

Search for Jobs